Table 5.
Allele and genotype frequencies of dopamine receptor polymorphism in responder and non responder groups in patient population based on percent response score ≤ 50% ≥.
Locus | Genotype Frequency | χ2 | P | Allele Frequency | χ2 | P | |||
Taq1B (rs 1079597) | B1B1 | B1B2 | B2B2 | 0.18 | 0.915 | B1 | B2 | 0.15 | 0.7 |
Responders(n = 121) | 0.04(5) | 0.42(51) | 0.54(65) | 0.25(61) | 0.751(181) | ||||
Nonresponders(n = 59) | 0.05(3) | 0.44(26) | 0.51(30) | 0.27(32) | 0.73(86) | ||||
Taq1D 1 (rs 1800498) | D1D1 | D1D2 | D2D2 | 6.14 | 0.046* | D1 | D2 | 0.65 | 0.42 |
Responders (n = 121) | 0.15(18) | 0.54(65) | 0.31(38) | 0.42(101) | 0.58(141) | ||||
Nonresponders(n = 59) | 0.03(2) | 0.68(40) | 0.29(17) | 0.37(44) | 0.63(74) | ||||
S311C (rs 1801028) | GG | GC | CC | 0.99 | 0.61 | G | C | 0.26 | 0.61 |
Responders (n = 120) | 0.79(95) | 0.19(23) | 0.02(2) | 0.89(213) | 0.11(27) | ||||
Nonresponders(n = 58) | 0.81(47) | 0.19(11) | (0) | 0.90 (105) | 0.10(11) | ||||
H313H2 (rs 6275) | TT | TC | CC | 5.57 | 0.06 | T | C | 1.76 | 0.18 |
Responders (n = 122) | 0.36(44) | 0.41(50) | 0.23(28) | 0.57(138) | 0.43(106) | ||||
Nonresponders(n = 59) | 0.20(12) | 0.58(34) | 0.22(13) | 0.49(58) | 0.51(60) | ||||
Taq1A (rs 1800497) | A1A1 | A1A2 | A2A2 | 1.91 | 0.39 | A1 | A2 | 1.44 | 0.23 |
Responders (n = 121) | 0.09(10) | 0.42(51) | 0.49(60) | 0.29(71) | 0.71(171) | ||||
Nonresponders(n = 59) | 0.08(5) | 0.53(31) | 0.39(23) | 0.35(41) | 0.65(74) |
1Taq1D recessive model (D1D1vs D1D2 +D2D2) P = 0.023, Odds = 4.98, CI = 1.115 to 22.25
2H313H dominant model (TT Vs TC+CC) P = 0.0490, Odds = 0.490, CI = 0.2394 to 1.004